mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / lantus solostar

Lantus Solostar

Insulin Glargine
  |==|
  |  |
  |__|
  dose

Insulin Glargine is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyInsulin Glargine
administration routeOral
price comparison status2 snapshots
safety signal rating46 / 100
animalDailyMed SPL indexDailyMed SPL
price index

Ingredient Reference Prices

⚠ Direct price snapshots for this brand/package are not staged yet. Showing verified reference prices for active ingredient: Insulin Glargine.
$35USvsCA$61.69CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 69595 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Falling3M: -2%12M: -7.1%
Jul 2025
██▇▆▆▅▄▃▃▂
Jun 2026
Jan 2026$36.33
Feb 2026$36.09
Mar 2026$35.84
Apr 2026$35.60
May 2026$35.35
Jun 2026$35.11
01 / chemistryMaker not enriched yet

Ingredient Breakdown

active moietyInsulin Glargine
formulationOral animal
mechanism of action

animal

available strengths
Strength varies by package/NDC; inspect source label before comparing prices.

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Confirm ingredient, dose, timing, food instructions, and interaction warnings with a clinician or pharmacist.
  2. Use the same ingredient name when comparing brand, generic, country, and pharmacy options.
  3. Do not split, crush, stop, or substitute extended-release products unless the label or clinician says so.
  4. Watch for severe allergic reactions, bleeding, mood changes, breathing issues, or other label-specific red flags.

Side-Effect Signals

  • low blood sugar
  • injection-site reactions
  • weight change
  • dose-timing errors
  • severe hypoglycemia warning
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
LantusSoliqua 100/33Basaglar Kwikpen , Basaglar Tempo Pen (Insulin Glargine) Injection, SolutionInsulin Glargine U-300 , Insulin Glargine U-300 Max (Insulin Glargine) Injection, SolutionLantus , Lantus Solostar (Insulin Glargine) Injection, SolutionToujeo , Toujeo Max (Insulin Glargine) Injection, SolutionInsulin Glargine SolostarToujeo Max